By vgreene, 24 December, 2014 Palivizumab prophylaxis not recommended routinely; may consider<sup>4</sup> for children <24 mo of age who are profoundly immunocompromised (eg, stem cell transplant pts) during RSV season
By vgreene, 24 December, 2014 Palivizumab prophylaxis not routinely recommended unless coexisting CHD/CLDP<sup>4</sup>
By vgreene, 24 December, 2014 Palivizumab prophylaxis not routinely recommended; may consider<sup>4</sup> if <12 mo old w/ impaired ability to clear lower airway secretions
By vgreene, 24 December, 2014 Palivizumab prophylaxis not routinely recommended; may consider<sup>4</sup> if <12 mo old and w/ CLD and/or nutritional compromise, or in 2nd yr of life if manifestations of severe lung dz<sup>7</sup> or weight for length <10th percentile
By vgreene, 24 December, 2014 Administer palivizumab<sup>4</sup> during 1st yr of life [B/M]; consider another season of palivizumab prophylaxis in the 2nd yr of life if pt continues to require medical support<sup>6</sup>